Neonatal Jaundice Phototherapy Thresholds

Plot total serum bilirubin (TSB) against the 2022 AAP hour-specific phototherapy threshold using the infant’s exact postnatal age, gestational age, and presence or absence of bilirubin neurotoxicity risk factors. The revised AAP thresholds for both phototherapy and exchange transfusion are higher than those in the 2004 guidance. ScienceDirect+4ScienceDirectNeonatal jaundice: Recommendations for follow-up and treatmentpublications aapWhat’s Up (And Down) With the New Bilirubin Guidelines | AAP Journal Blogs | American Academy of Pediatricspublications aapBilirubin Measurement and Phototherapy Use After the AAP 2022 Newborn Hyperbilirubinemia Guideline | Pediatrics | American Academy of Pediatricspublications aapAAP releases updated guidance for managing neonatal hyperbilirubinemia | AAP News | American Academy of Pediatricspediatrics aappublicationsManagement of Hyperbilirubinemia in the Newborn Infant 35 or ...

Gestational age is incorporated directly into the treatment threshold. Use the risk-factor threshold rather than the no-additional-risk-factor threshold when there is low albumin, isoimmune or other hemolytic disease, sepsis, or clinical instability. These factors increase bilirubin neurotoxicity risk and lower the treatment threshold selected for a given age and gestational age. publications aappublications aapAAP releases updated guidance for managing neonatal hyperbilirubinemia | AAP News | American Academy of Pediatrics

A visible jaundice pattern should not substitute for a bilirubin value. Use transcutaneous bilirubinometry as screening when available, but obtain TSB for threshold-based treatment decisions and for an infant receiving or recently completing phototherapy. TcB after phototherapy underestimates TSB by a mean 2.4 mg/dL, with substantial variability. Nature+1NatureManagement of Neonatal Hyperbilirubinemia | Neonatology | Paediatrics | Health sciences | Topics | Nature Indexpediatrics aappublicationsTranscutaneous Bilirubin After Phototherapy in Term and Preterm ...

Measure bilirubin promptly when jaundice is recognized during the first 24 hours after birth. This pattern is associated with severe hyperbilirubinemia and should shift the evaluation toward isoimmune hemolysis, other hemolytic disease, bruising or cephalhematoma, and G6PD deficiency rather than routine observation. BMJ+1BMJIncidence and causes of severe neonatal hyperbilirubinemia in Canadapublications aapAAP releases updated guidance for managing neonatal hyperbilirubinemia | AAP News | American Academy of Pediatrics

Review maternal antibody status and identify maternal anti-erythrocyte antibodies before discharge. If isoimmune disease or another hemolytic process is present, apply the neurotoxicity risk-factor treatment threshold and monitor the TSB trajectory closely because hemolysis can drive rapid bilirubin accumulation. Wolters Kluwer+1Wolters KluwerIntravenous Immunoglobulin in Hemolytic Disease... : Nigerian Journal of Clinical Practicepublications aapAAP releases updated guidance for managing neonatal hyperbilirubinemia | AAP News | American Academy of Pediatrics

Ask specifically about a prior sibling treated with phototherapy, gestational age of 35 to 36 weeks, poor feeding, bruising, cephalhematoma, and family ancestry or history compatible with G6PD deficiency. The 2022 AAP approach removed race as a risk factor; clinical assessment should instead identify biologically relevant risks such as G6PD deficiency and hemolysis. BMJ+3BMJIncidence and causes of severe neonatal hyperbilirubinemia in CanadaScienceDirectNeonatal jaundice: Recommendations for follow-up and treatmentpublications aapWhat’s Up (And Down) With the New Bilirubin Guidelines | AAP Journal Blogs | American Academy of Pediatricspublications aapAAP releases updated guidance for managing neonatal hyperbilirubinemia | AAP News | American Academy of Pediatrics

When TSB meets the applicable AAP phototherapy threshold, start phototherapy rather than waiting for jaundice progression. Phototherapy lowers unconjugated bilirubin by converting it into water-soluble isomers for excretion and has markedly reduced the need for exchange transfusion. Nature+1NatureManagement of Neonatal Hyperbilirubinemia | Neonatology | Paediatrics | Health sciences | Topics | Nature IndexCDC[PDF] Phototherapy to Prevent Severe Neonatal Hyperbilirubinemia in the ...

For severe hyperbilirubinemia or an infant approaching escalation, use intensive phototherapy with optimized irradiance. Bilirubin absorbs blue light most strongly around 460 nm; the reported effective phototherapy range is 460 to 490 nm, optimally 478 nm. An irradiance of at least 30 microwatts/cm² at 478 nm is cited for intensive treatment. BMJBMJNeonatal jaundice - Treatment algorithm | BMJ Best Practice

Verify the actual device irradiance at the infant’s skin surface, maximize exposed skin area, and avoid assuming that a second device is equivalent to adequate delivered light dose. Overhead LED phototherapy has been associated with a faster TSB decline and shorter treatment duration than conventional compact fluorescent or halogen systems; double-light therapy is often used to increase irradiance. BMJBMJNeonatal jaundice - Treatment algorithm | BMJ Best Practice

Maintain feeding assessment and clinical monitoring during treatment, but do not delay indicated phototherapy while addressing intake. Phototherapy is contraindicated in congenital porphyria and in infants receiving photosensitizing drugs. CDCCDC[PDF] Phototherapy to Prevent Severe Neonatal Hyperbilirubinemia in the ...

Use the AAP escalation-of-care framework when TSB approaches the exchange-transfusion threshold. The 2022 guideline added escalation-of-care risk assessment and includes separate exchange-transfusion nomograms based on postnatal age, gestational age, and neurotoxicity risk factors. ScienceDirect+3ScienceDirectNeonatal jaundice: Recommendations for follow-up and treatmentpublications aapBilirubin Measurement and Phototherapy Use After the AAP 2022 Newborn Hyperbilirubinemia Guideline | Pediatrics | American Academy of Pediatricspublications aapAAP releases updated guidance for managing neonatal hyperbilirubinemia | AAP News | American Academy of Pediatricspediatrics aappublicationsManagement of Hyperbilirubinemia in the Newborn Infant 35 or ...

Treat signs of acute bilirubin encephalopathy as an emergency: hypertonia, arching, retrocollis, opisthotonos, fever, high-pitched cry, or recurrent apnea warrant immediate exchange transfusion, even when TSB is falling. Start phototherapy while preparing for exchange transfusion and continue it afterward. BMJBMJNeonatal jaundice - Treatment algorithm | BMJ Best Practice

Exchange transfusion is a rescue intervention for severe hyperbilirubinemia and remains a critical procedure despite becoming uncommon in high-resource settings. It rapidly lowers bilirubin and antibody burden in severe hemolytic disease, but requires procedural expertise and carries meaningful procedural risk. Nature+1NatureManagement of Neonatal Hyperbilirubinemia | Neonatology | Paediatrics | Health sciences | Topics | Nature IndexScienceDirectBlood Exchange Transfusion for Infants with Severe Neonatal Hyperbilirubinemia

Before discharge, obtain bilirubin screening with TSB or TcB and calculate the difference between the measured bilirubin and the applicable hour-specific phototherapy threshold. The smaller this difference, the closer and earlier the follow-up bilirubin assessment should be. This replaces the earlier approach of using a predischarge risk-zone classification alone. Nature+1NatureManagement of Neonatal Hyperbilirubinemia | Neonatology | Paediatrics | Health sciences | Topics | Nature Indexpublications aapAAP releases updated guidance for managing neonatal hyperbilirubinemia | AAP News | American Academy of Pediatrics

Include feeding adequacy, clinical stability, gestational age, visible jaundice progression, and hemolysis risk in the discharge decision. Lower gestational age, jaundice in the first 24 hours, poor feeding, and maternal anti-erythrocyte antibodies identify infants needing more cautious surveillance. BMJ+1BMJIncidence and causes of severe neonatal hyperbilirubinemia in Canadapublications aapAAP releases updated guidance for managing neonatal hyperbilirubinemia | AAP News | American Academy of Pediatrics

After phototherapy is discontinued, obtain planned follow-up assessment for rebound hyperbilirubinemia according to the AAP follow-up recommendations. Use TSB for a rebound decision when recent phototherapy makes TcB potentially inaccurate. publications aap+1publications aapAAP releases updated guidance for managing neonatal hyperbilirubinemia | AAP News | American Academy of Pediatricspediatrics aappublicationsTranscutaneous Bilirubin After Phototherapy in Term and Preterm ...